Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Chen

Showing results (151-160 of 274) with videos related to

Pageof 28
Sort By:
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
Genome Research|October 25, 2012
Modeling kinetic rate variation in third generation DNA sequencing data to detect putative modifications to DNA basesEric E Schadt, Onureena Banerjee, Gang Fang, et al.
Targeted Oncology|January 25, 2013
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptNicole Shonka, Yuji Piao, Mark Gilbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2025
Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Sarcoma|February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)AeRang Kim, Yao Lu, Scott H Okuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database AnalysisSaskia Litière, Gaëlle Isaac, Elisabeth G E De Vries, et al.
Biomolecules|October 23, 2021
Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD TauopathiesMarta Del Campo, Yolande A L Pijnenburg, Alice Chen-Plotkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Designing phase 0 cancer clinical trialsAnthony J Murgo, Shivaani Kummar, Larry Rubinstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative diseaseKatheryn A Q Cousins, Jeffrey S Phillips, Sandhitsu R Das, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Pageof 28

Showing results (151-160 of 274) with videos related to

Sort By:
Pageof 28
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
Genome Research|October 25, 2012
Modeling kinetic rate variation in third generation DNA sequencing data to detect putative modifications to DNA basesEric E Schadt, Onureena Banerjee, Gang Fang, et al.
Targeted Oncology|January 25, 2013
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptNicole Shonka, Yuji Piao, Mark Gilbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2025
Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Sarcoma|February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)AeRang Kim, Yao Lu, Scott H Okuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database AnalysisSaskia Litière, Gaëlle Isaac, Elisabeth G E De Vries, et al.
Biomolecules|October 23, 2021
Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD TauopathiesMarta Del Campo, Yolande A L Pijnenburg, Alice Chen-Plotkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Designing phase 0 cancer clinical trialsAnthony J Murgo, Shivaani Kummar, Larry Rubinstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative diseaseKatheryn A Q Cousins, Jeffrey S Phillips, Sandhitsu R Das, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Pageof 28